# Fulcrum Therapeutics, Inc.: Form 8-K, filed Jul 10, 2023

- Company: [Fulcrum Therapeutics, Inc.](/companies/fulc.md) (CIK 1680581)
- Form: 8-K
- Filed: 2023-07-10
- Accepted by EDGAR: Jul 10, 2023, 17:06 ET
- Period: 2023-07-05
- Accession: 0001193125-23-184748
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1680581/000119312523184748/d443448d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1680581/000119312523184748/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1680581/000119312523184748/d443448d8k.htm

Filed Jul 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-184748. Last ingested by Listed: Nov 13, 2026, 16:05 ET. No prices; not investment advice.